Hearing:
“The Role of Purdue Pharma and the Sackler Family in the Opioid Epidemic”
Committee on Oversight and Reform
Thursday, December 17, 2020 (9:00 AM)
Meeting was rescheduled to the time and date listed above.
Select one
Washington, D.C.
This hearing is fully remote via WebEx. This hearing has been rescheduled from 12/15 to 12/17.
Witnesses
Mr. Craig Landau
President and CEO, Purdue Pharma L.P.
Added
12/16/2020 at 04:43 PM
- Witness Statement
[PDF]
Added
12/17/2020 at 12:49 PM
Mr. David Sackler
Former Member of the Board of Directors, Purdue Pharma L.P.
Added
12/16/2020 at 04:43 PM
- Witness Statement
[PDF]
Added
12/17/2020 at 12:49 PM
Dr. Kathe A. Sackler
Former Vice President and Member of the Board of Directors, Purdue Pharma L.P.
Added
12/16/2020 at 04:43 PM
- Witness Statement
[PDF]
Added
12/17/2020 at 12:49 PM
Support Documents
- Notice
[PDF]
Added
12/08/2020 at 02:33 PM
- Memo
[PDF]
Added
12/08/2020 at 02:33 PM
- Rescheduled Notice
[PDF]
Added
12/11/2020 at 01:20 PM
- UC - Chairwoman Maloney - Maura Healey Statement
[PDF]
Added
01/21/2021 at 11:30 AM
- UC - Rep Raskin - Letter from State Attorney General offices
[PDF]
Added
01/21/2021 at 11:30 AM
- Patient Testimonials
[PDF]
Added
01/21/2021 at 11:36 AM
Hearing Record
- Attendance
[PDF]
Added
12/17/2020 at 04:31 PM
- QFR Responses from Purdue to Chairwoman Maloney and Rep Raskin
[PDF]
Added
01/30/2021 at 03:09 PM
- QFR Responses from David Sackler
[PDF]
Added
02/02/2021 at 01:14 PM
- QFR Responses from Kathe Sackler
[PDF]
Added
03/03/2021 at 11:12 AM
- Letter from Mr. Landau's attorney regarding the Hearing Transcript. Requested change - discrepancies in transcript
[PDF]
Added
03/23/2021 at 12:49 PM
- Hearing Transcript with Errata I & II
[PDF]
Added
06/13/2022 at 07:10 PM
First Published:
December 8, 2020 at 02:27 PM
Last Updated:
June 13, 2022 at 07:10 PM